HKHidenobu Kojima

Hidenobu Kojima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hidenobu Kojima has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pancreas–Intestine Composite Transplantation for Simultaneous Loss of Pancreatic and Intestinal Function (With Video)

    byĀ Kei Yamane, Takashi Ito, Takayuki Anazawa, Junji Fujikura, Makoto Okabe, Satoshi Ishida, Koki Kurahashi, Masaaki Hirata, Hiroshi Kawamoto, Hiroto Nishino, et al.

    Pancreas–intestine composite transplantation (PITx) is a therapeutic option for patients with irreversible loss of both pancreatic and intestinal function. We report a case of PITx in a 16‐year‐old male who developed fulminant Type 1 diabetes mellitus complicated by non‐occlusive mesenteric ischemia, resulting in extensive intestinal necrosis. Despite intensive surgical and critical care management, the patient ultimately required total small intestinal resection and total pancreatectomy. After recovery from sepsis and multiorgan dysfunction, the patient's general condition stabilized, and PITx was considered an appropriate therapeutic option. The composite graft consisted of the pancreas, duodenum, small intestine, and right colon. Arterial inflow was reconstructed using a single Carrel patch incorporating the celiac axis and superior mesenteric artery, and venous outflow was established by portal vein anastomosis. Postoperatively, pancreatic endocrine function was restored, allowing stable glycemic control without exogenous insulin, and intestinal graft function enabled the gradual advancement of enteral and oral nutrition. This report highlights the key technical considerations and anatomical principles of PITx and demonstrates that tailored composite graft transplantation can restore both pancreatic and intestinal function while preserving unaffected abdominal organs in highly selected patients with combined pancreatic and intestinal failure.

  • Open Access

    Notation System for Liver Transplant Recipients: Key Information in Transplant Procedure

    byĀ Hidenobu Kojima, Takashi Ito, Kei Yamane, Tomoaki Yoh, Shinya Okumura, Katsunori Sakamoto, Shoichi Kageyama, Satoshi Ogiso, Takayuki Anazawa, Yoichiro Uchida, et al.

    Liver transplantation (LT) is a standard therapy for patients with end‐stage liver disease and certain hepatic malignancies. The LT procedure has diversified due to donor shortages and advances in immunosuppressive treatments and surgical techniques. Donor organ shortages have promoted the use of living donor liver transplantation and ā€œmarginalā€ livers, including donation after circulatory death. ABO‐incompatible liver transplants now show outcomes comparable with ABO‐compatible transplants when a desensitization protocol is used. Hepaticojejunostomy, rather than duct‐to‐duct anastomosis, is performed in select cases with an unsuitable common bile duct or in patients with primary sclerosing cholangitis. These procedural differences affect follow‐up management in LT recipients. Given the increasing diversity of transplant surgeries and the long‐term prognosis after LT, it is essential for healthcare professionals and transplant societies to be informed about the specific procedures performed in LT recipients. We aimed to propose a notation system for LT recipients that documents key procedural information, including the number of transplantations, donor type with donor/recipient blood types in ABO‐incompatible transplantation, graft type, the number of reconstructed vessels, and the number and type of biliary reconstruction. The use of a common notation system for transplant procedures can facilitate patient management, communication, and accurate understanding of transplant procedures.

  • Regeneration of the Human Intrahepatic Nervous System in Living Donor Liver Transplantation Recipients

    byĀ Yusuke Hanabata, Takamichi Ishii, Kenta Makino, Takuma Karasuyama, Kentaro Iwaki, Fumiaki Munekage, Hiroshi Horie, Elena Yukie Uebayashi, Hidenobu Kojima, Satoshi Ogiso, et al.

    Aim: Nerve fibers in the liver help to regulate blood flow and metabolism. They spread from the porta hepatis along the Glissonean sheath (GS) to the hepatocytes and the surrounding areas. In liver transplants, these nerves are completely resected, but their regeneration is not well known. This study examined how and when these nerves regenerate following living donor liver transplantation (LDLT). Methods: The study included 7 patients who underwent LDLT, with follow‐up periods ranging from 5 to 27 years. Six patients underwent follow‐up biopsies, and 1 patient underwent whole‐liver re‐transplantation. A biopsy specimen obtained during transplantation was used as the control. Nerve regeneration was assessed using synaptophysin immunohistological staining to detect nerve fibers. Results: In 6 cases, nerve fibers disappeared soon after the transplant and were not observed for months or years. In three cases with follow‐up periods exceeding 15 years, nerve fibers were observed around the GS only after more than 15 years had elapsed. In the re‐transplanted liver, thick nerve fibers grew around the large GS, but thin fibers did not appear around the smaller GS or within liver lobules. Conclusions: Nerve fibers from donor liver diminished immediately after LDLT. They grew mainly around the medium to large GS, with little or no growth within the lobules.


  • Suture Techniques for Vascular Reconstruction in Mouse Orthotopic Liver Transplantation

    byĀ Hidenobu Kojima, Kosuke Tanaka, Shoichi Kageyama, Satoshi Ogiso, Takayuki Anazawa, Yoichiro Uchida, Kazuyuki Nagai, Takashi Ito, Takamichi Ishii, Etsuro Hatano

    Translational research using animal models is essential for addressing the clinical issues in organ transplantations. Although mouse orthotopic liver transplantation (LT) is a useful tool for investigating the mechanisms of liver regeneration, ischemia-reperfusion injury, and immune responses following LT, technical challenges in this procedure restrict its feasibility. The key aspects for successful mouse orthotopic LT are vascular reconstruction in recipients, including the suprahepatic inferior vena cava (SHIVC), portal vein (PV), and infrahepatic inferior vena cava (IHIVC). In addition to the technical difficulties in reconstructing these vessels, the time limitation of the anhepatic phase to within 20 min makes this procedure more challenging. Although a cuff technique can be used for PV reconstruction, a safe and quick suture technique is required to reconstruct the SHIVC during the anhepatic phase. For IHIVC reconstruction, while both cuff and suture techniques are applicable, the suture technique leads to a shorter operation time in donor surgery and back-table preparation and can maintain a larger vascular lumen than the cuff technique. We herein provide guidelines for SHIVC and IHIVC reconstruction using a suture technique to facilitate mouse orthotopic LT.

  • JoVE Video Dataset

    byĀ Hidenobu Kojima, Kosuke Tanaka, Shoichi Kageyama, Satoshi Ogiso, Takayuki Anazawa, Yoichiro Uchida, Kazuyuki Nagai, Takashi Ito, Takamichi Ishii, Etsuro Hatano

    Translational research using animal models is essential for addressing the clinical issues in organ transplantations. Although mouse orthotopic liver transplantation (LT) is a useful tool for investigating the mechanisms of liver regeneration, ischemia-reperfusion injury, and immune responses following LT, technical challenges in this procedure restrict its feasibility. The key aspects for successful mouse orthotopic LT are vascular reconstruction in recipients, including the suprahepatic inferior vena cava (SHIVC), portal vein (PV), and infrahepatic inferior vena cava (IHIVC). In addition to the technical difficulties in reconstructing these vessels, the time limitation of the anhepatic phase to within 20 min makes this procedure more challenging. Although a cuff technique can be used for PV reconstruction, a safe and quick suture technique is required to reconstruct the SHIVC during the anhepatic phase. For IHIVC reconstruction, while both cuff and suture techniques are applicable, the suture technique leads to a shorter operation time in donor surgery and back-table preparation and can maintain a larger vascular lumen than the cuff technique. We herein provide guidelines for SHIVC and IHIVC reconstruction using a suture technique to facilitate mouse orthotopic LT.

  • Open Access

    Recipient toll-like receptor 4 determines the outcome of ischemia-reperfusion injury in steatotic liver transplantation in mice

    byĀ Kosuke Tanaka, Yoichiro Uchida, Kentaro Kadono, Shoichi Kageyama, Hiroshi Kawamoto, Masaaki Ito, Yuki Kidoguchi, Kenichi Saga, Hidenobu Kojima, Hirofumi Hirao, et al.


  • Open Access

    Group 1 innate lymphoid cells protect liver transplants from ischemia-reperfusion injury via an interferon gamma–mediated pathway

    byĀ Hidenobu Kojima, Thomas A. Morinelli, Yue Wang, Jackson L. Chin, Aaron S. Meyer, Yi-Chu Kao, Kentaro Kadono, Siyuan Yao, Taylor Torgerson, Kenneth J. Dery, et al.


  • Open Access

    Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation

    byĀ Allyson Q. Terry, Hidenobu Kojima, Rebecca A. Sosa, Fady M. Kaldas, Jackson L. Chin, Ying Zheng, Bita V. Naini, Daisuke Noguchi, Jessica Nevarez-Mejia, Yi-Ping Jin, et al.


  • Open Access

    Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury

    byĀ Kojiro Nakamura, Shoichi Kageyama, Fady M. Kaldas, Hirofumi Hirao, Takahiro Ito, Kentaro Kadono, Kenneth J. Dery, Hidenobu Kojima, David W. Gjertson, Rebecca A. Sosa, et al.

    Although CEACAM1 (CC1) glycoprotein resides at the interface of immune liver injury and metabolic homeostasis, its role in orthotopic liver transplantation (OLT) remains elusive. We aimed to determine whether/how CEACAM1 signaling may affect hepatic ischemia-reperfusion injury (IRI) and OLT outcomes. In the mouse, donor liver CC1 null mutation augmented IRI-OLT (CC1-KO→WT) by enhancing ROS expression and HMGB1 translocation during cold storage, data supported by in vitro studies where hepatic flush from CC1-deficient livers enhanced macrophage activation in bone marrow–derived macrophage cultures. Although hepatic CC1 deficiency augmented cold stress–triggered ASK1/p-p38 upregulation, adjunctive ASK1 inhibition alleviated IRI and improved OLT survival by suppressing p-p38 upregulation, ROS induction, and HMGB1 translocation (CC1-KO→WT), whereas ASK1 silencing (siRNA) promoted cytoprotection in cold-stressed and damage-prone CC1-deficient hepatocyte cultures. Consistent with mouse data, CEACAM1 expression in 60 human donor liver biopsies correlated negatively with activation of the ASK1/p-p38 axis, whereas low CC1 levels associated with increased ROS and HMGB1 translocation, enhanced innate and adaptive immune responses, and inferior early OLT function. Notably, reduced donor liver CEACAM1 expression was identified as one of the independent predictors for early allograft dysfunction (EAD) in human OLT patients. Thus, as a checkpoint regulator of IR stress and sterile inflammation, CEACAM1 may be considered as a denominator of donor hepatic tissue quality, and a target for therapeutic modulation in OLT recipients.